Dr. Xinan Zhang is an Associate Professor in the School of Engineering at The University of Western Australia (UWA), specializing in Electrical, Electronic, and Computer Engineering. He holds a BEng from Fudan University (2008) and a PhD from Nanyang Technological University (2014). Before joining UWA in 2019, he held roles as a Lecturer and Research Fellow in Singapore and Australia. His research focuses on power electronics, electrical machine drives, and renewable energy, with over 60 top-tier publications. He is the Portfolio Lead for Industry Engagement in UWA's School of Engineering and co-leads the Power and Clean Energy (PACE) research group. Education: BEng in Electrical Engineering, Fudan University (2004–2008) PhD in Electrical Engineering, Nanyang Technological University (2010–2014) Research Interests: Dr. Zhang’s work spans power electronics, renewable energy systems, energy storage, and smart grid technologies. He emphasizes practical applications, such as battery management systems for vanadium redox flow batteries and adaptive control strategies for microgrids. His contributions address challenges in energy efficiency, grid stability, and sustainable power solutions. Articles & Trends: Recent publications focus on advanced control algorithms for inverters, battery modeling, and renewable energy integration. His work combines data-driven methods with traditional control theory to enhance system efficiency and reliability. Notable areas include DC microgrid control, vanadium redox flow battery optimization, and model predictive control for power electronics. Awards: Listed in Stanford University’s Top 2% Scientists (2020–2022) Grants & Collaborations: He leads or co-leads projects funded by the Australian government and industry partners, including the GenX Betavoltaic Battery Pilot Manufacturing Process and Mine Electrification . These projects aim to advance clean energy technologies and industrial applications. Labs & Teams: As co-lead of the PACE group, he fosters interdisciplinary collaboration to tackle global energy challenges, aligning with UN Sustainable Development Goals for affordable and clean energy (SDG 7).
Dr. Yogambha Ramaswamy is a Senior Lecturer in the School of Biomedical Engineering at The University of Sydney and a member of the Sydney Nano Institute. She holds a Master’s in Biotechnology from the University of Queensland and a PhD in Biomedical Engineering from the University of Sydney (2009). Her postdoctoral career began as a Vice-Chancellor’s Postdoctoral Research Fellow at the University of New South Wales, followed by a Peter Doherty Early Career Fellowship in 2013 before joining the University of Sydney in 2015. Dr. Ramaswamy’s research focuses on biomaterials, tissue engineering, and mechanobiology, with a particular emphasis on developing calcium silicate-based ceramics and biopolymers for orthopedic and regenerative applications. Her recent work explores the role of physical cues in modulating stem and cancer cell behavior. She teaches courses such as AMME1961 (Introduction to Biomedical Engineering B) and AMME5962 (Introduction to Mechanobiology). Her research has been supported by grants including the NHMRC Early Career Fellowship and collaborations with institutions like the CSIR-Indian Institute of Chemical Technology and the University of Otago. Her publications span biomaterials, nanotechnology, and mechanobiology, with recent work addressing atherosclerosis, hydrogel design, and nanomedicine. She currently supervises PhD students Frank (biomaterials) and Alexander (atherosclerosis research).
Dr. Susan Hua is an Associate Professor at the University of Newcastle's School of Biomedical Sciences and Pharmacy, specializing in translational nanopharmaceutics and therapeutic targeting. She established the first translational nanopharmaceutics laboratory in the Hunter region, focusing on drug delivery systems for gastrointestinal, musculoskeletal, and reproductive pathologies. Education: Bachelor of Pharmacy with Honours, University of Queensland (UQ) PhD in Neuroscience and Nanotechnology, UQ Research Interests: Her work centers on using nanotechnology to create targeted drug delivery systems for diseases such as chronic pain, inflammatory conditions, and obstetric complications. Key focuses include oxytocin receptor-targeted liposomes for uterine therapies and localized drug delivery to bypass biological barriers. Awards & Recognition: 2020 DVC(A) Educator Innovation Award 2017 NSW Premier's Early Career Researcher of the Year 2015 HMRI Early Career Researcher of the Year Grants & Collaborations: A/Prof Hua has secured over $5.5M in grants, including NHMRC and ARC funding. She collaborates with institutions like HMRI, John Hunter Hospital, and global teams on projects like nanoparticle-based treatments for preterm labor and uterine hemorrhage. Teaching & Leadership: She coordinates pharmacy programs, emphasizing clinical application and innovation. Her courses include Pharmacotherapeutics and Pharmacy Practice, with awards for teaching excellence (2020, 2011). Labs & Programs: Head of Therapeutic Targeting Program, University of Newcastle Director, Translational Pharmaceutics & Medical Technologies Theme (HMRI)
Professor Hala Zreiqat AM is a leading biomedical engineer at The University of Sydney , serving as the Director of the ARC Training Centre for Innovative BioEngineering . A Fellow of all major Australian academies (AAS, ATSE, FAHMS, FRSN), she develops 3D printed bioceramics for bone regeneration while championing diversity through initiatives like the IDEAL Society and BIOTech Futures mentorship program. Her work bridges academia, clinical practice, and industry in musculoskeletal research . Research Focus: Her lab creates synthetic bone scaffolds that mimic natural bone architecture, strength, and porosity, enabling non-rejected bone regeneration via patient-matched implants. Key applications include orthopaedic, dental, and maxillofacial repair , with over $18M in competitive funding and multiple patents. Current projects explore AI-driven scaffold performance prediction and anti-senescence strategies for aging-related bone loss. Scientific Trends: Recent publications highlight 3D printed nanovoxelated ceramics , antisenescence biomaterials , and multifunctional theranostic platforms . Her team integrates machine learning for scaffold design, atom probe tomography for interface analysis, and two-photon imaging for cellular monitoring in 3D environments. 2021-2022 Fulbright Senior Scholar 2018 NSW Premier's Woman of the Year 2019 Eureka Prize for Innovative Use of Technology Fellow of Australian Academy of Science (2021) Over $18M in research funding Teaching & Leadership: She designed core courses like Tissue Engineering and Nanomaterials in Medicine , mentoring 158 students in 2020 alone. As Chair of CAAR (2020-2023), she strengthens Australia-Arab collaborations. Her lab trains early-career researchers , with alumni now in academia and industry.
Dr. Yi Shen is a Senior Lecturer at the School of Chemical and Biomolecular Engineering, The University of Sydney, and Chair of RACI Women in Chemistry. She is also affiliated with multiple research institutes including Sydney Institute of Agriculture, Sydney Southeast Asia Centre, The Centre for Drug Discovery Innovation, and The University of Sydney Nano Institute. PhD in Soft Materials from ETH Zurich Postdoctoral research at University of Cambridge and Harvard University Her research focuses on protein phase behavior and functional biomaterials development, utilizing soft matter approaches and microfluidic techniques to address challenges in neurodegenerative diseases, sustainable materials, and biomedical engineering. She has published extensively in top journals like Nature Nanotechnology and PNAS, with a particular emphasis on: Protein liquid-liquid phase separation mechanisms Biomaterials from protein nanofibrils Microfluidic manipulation of biological systems Biodegradable bioplastics development Shear force effects on biomolecular systems Pathological protein aggregation dynamics Key scientific achievements include: 2022 ARC DECRA Fellowship 2022 Sydney Nano Frontier award 2018 ETH Zurich Spark Award (for Fe delivery system invention) 2012 Princeton Grand Challenges Program 2 patents pending 2 Nature Nanotechnology cover articles As an educator, she coordinates CHNG2802 Chemical Engineering Modelling and Analysis, co-teaches CHNG3804 Biochemical Engineering and CHNG5605 Bio-products: Laboratory to Marketplace, and guest lectures across biomedical and nanotechnology programs. Her lab actively collaborates with institutions in Switzerland (ETH Zurich), UK (Cambridge), and US (Harvard, Princeton), focusing on transforming biomolecular understanding into real-world applications in health, industry, and environmental sustainability.
Dr. Paula Gonzalez-Figueroa is a Research Fellow at the Clinical Hub for Interventional Research (CHOIR) in the College of Health and Medicine at The Australian National University (ANU). She holds a PhD in Medical Sciences from ANU and completed postdoctoral research at the John Curtin School of Medical Research (ANU) and the Francis Crick Institute (UK). Her research focuses on immunology, autoimmunity, allergy, and clinical translation. Education: PhD in Medical Sciences (ANU), Biotechnology degree. Research Interests: Regulatory T cells, germinal centers, B cell biology, neuritin-based therapies, preclinical drug testing, and early-phase clinical trials. Affiliations: CHOIR (Researcher), Polizzotto Group, Genome Sciences and Cancer Division. Her work includes developing a neuritin-based biotherapeutic for allergies and autoimmune diseases, and leading preclinical/Phase I clinical programs for hematological cancers. She has contributed to studies on Tfr cell regulation, IgE responses, and germinal center dynamics. Publications span immunology, molecular biology, and translational research, with notable contributions to Nature Immunology , Cell , and Journal of Experimental Medicine .
Prof. Xiaojing Huang is a Professor of Information and Communications Technology at the University of Technology Sydney (UTS), serving as Head of Discipline for SEDE Communications and Electronics within the School of Electrical and Data Engineering. He leads the Mobile Sensing and Communications program at the Global Big Data Technologies Centre. With over 30 years of experience, he has authored over 300 publications and 31 patents, focusing on wireless communications, signal processing, and antenna technologies. Education: PhD (Electrical Engineering, Shanghai Jiao Tong University, 1989). Previous roles include Principal Research Scientist at CSIRO (2009-2014), Associate Professor at University of Wollongong (2004-2009), and key industry roles at Motorola and Shanghai Yang Tian Science and Technology Corporation. Research interests include full-duplex wireless systems, millimeter-wave and terahertz communications, massive antenna arrays, and mixed-signal processing platforms. His work on the CSIRO Ngara backhaul system earned multiple awards, including the 2012 CSIRO Chairman's Medal and Australian Engineering Innovation Award. Recent grants include $4.2M (AUD) for projects like 'Radio Frequency Camera for Radar Imaging' (ARC DP220101158) and 'Terabit mm-Wave Backbones for Integrated Space Networks' (ARC DP200101532). He has supervised numerous students in high-speed communication systems and full-duplex technologies. Awards include: 2013 CSIRO Leadership Achievement Award, 2012 Australian Engineering Innovation Award, and IEEE Sumner Award (nominee). Active in IEEE standards (802.11/802.15) and collaborations with institutions like Tsinghua University.
Professor Gavan McNally is a distinguished behavioral neuroscientist at the University of New South Wales, where he serves as a Professor in the School of Psychology. He is actively engaged in research on the fundamental behavioral and brain mechanisms for learning and motivation, with applications to clinical conditions such as addictions, anxiety disorders, and mood disorders. McNally holds several prestigious editorial positions, including Editor-in-Chief of Neurobiology of Learning & Memory and Senior Editor of The Journal of Neuroscience. He also serves as President-Elect of the European Behavioral Pharmacology Society and is a Member of the Australian Research Council College of Experts. McNally's research interests span behavioral neuroscience, focusing on how fundamental brain mechanisms apply to clinical conditions. He employs a systems neuroscience approach, combining well-controlled behavioral approaches with optogenetics, chemogenetics, in vivo calcium imaging, and whole brain circuit mapping in both normal and transgenic animals. His work bridges basic science with clinical applications through collaborations with colleagues at University of Sydney, Sydney Local Health District, Monash University, and Turning Point. McNally's research particularly examines the cellular, circuit, and systems level mechanisms underlying learning, motivation, and their dysregulation in disorders like addiction. His laboratory investigates how these mechanisms translate to human conditions, with a strong emphasis on developing new treatments for psychological disorders. His extensive publication record demonstrates a clear trajectory in understanding punishment learning, addiction mechanisms, and the neural circuits underlying motivated behavior. Recent work has increasingly focused on the cognitive pathways to punishment insensitivity, the role of specific neural circuits in addiction, and translational approaches to understanding maladaptive behaviors. McNally's research bridges animal models with human studies, creating a comprehensive understanding of the neural mechanisms that govern learning and motivation, with particular attention to how these processes go awry in addiction and other psychological disorders. 2008 QEII Fellow, Australian Research Council 2009 Association for Psychological Science, International Rising Star 2010 Fellow, Association for Psychological Science 2010 UNSW Faculty of Science Staff Excellence Award for Research and Training 2011 Pavlovian Research Award, The Pavlovian Society 2012 Future Fellow (Level 3), Australian Research Council 2016 D.G. Marquis Behavioral Neuroscience Award, American Psychological Association 2017 Fellow, American Psychological Association 2019 Fellow of the Academy of Social Sciences in Australia 2021 D.G. Marquis Behavioral Neuroscience Award, American Psychological Association 2022 Ross Day Plenary Lecturer, Australasian Brain and Psychological Sciences 2023 European Behavioural Pharmacology Society Plenary Lecturer 2024 Elspeth McLachlan Plenary Lecturer, Australasian Neuroscience Society 2024 D.G. Marquis Behavioral Neuroscience Award, American Psychological Association Professor McNally actively supervises several students including Bixuan Lin, Si Yin Lui, Hannah Machet, Bart Cooley, Kelly Zhuang, and Alexandra Gregory. His current research is supported by significant funding including an Australian Research Council Discovery Project (2024-2026) on "Risky choices: From cells and circuits to computations and behaviour," another Discovery Project (2025-2028) on "Multimodal mapping of punishment learning," and NHMRC grants including a Synergy Grant on "Linking clinical and basic science discovery to find new treatments for alcohol-use disorder" and an Ideas Grant on "Novel pathways to abstinence from alcohol seeking." These projects reflect his commitment to both fundamental neuroscience and translational applications for treating psychological conditions. His teaching responsibilities include PSYC2081 Learning & Physiological Psychology and PSYC3051 Physiological Psychology. McNally's laboratory employs advanced techniques including optogenetics, chemogenetics, in vivo calcium imaging, and whole brain circuit mapping to investigate the neural mechanisms underlying learning, motivation, and their dysregulation in disorders. His team works at the intersection of basic neuroscience and clinical applications, with strong collaborations across multiple institutions to translate fundamental findings into potential treatments for addiction and other psychological disorders. The lab has made significant contributions to understanding the role of brain regions like the ventral pallidum, paraventricular thalamus, and nucleus accumbens in addiction, fear learning, and punishment sensitivity.
Professor Oula Ghannoum is a renowned plant scientist and academic leader at the Hawkesbury Institute for the Environment (HIE), Western Sydney University. She serves as Director of the ARC Training Centre for Smart and Sustainable Horticulture and holds leadership roles, including Biological Sciences Discipline Lead and Associate Editor at Functional Plant Biology . Her research focuses on photosynthesis, global change biology, and protected cropping, aiming to enhance food security and climate resilience through crop improvement and sustainable agricultural practices. Education: BSc (Honours) in Plant Biochemistry, University of NSW (1993) PhD in Plant Physiology, Western Sydney University (1998) Research Interests: Professor Ghannoum’s work addresses global challenges like food security and climate change by exploring plant responses to environmental stress. Her lab uses advanced technologies like smart glasshouses and hyperspectral imaging to optimize crop yield and quality. Key areas include sugar signaling pathways in C3/C4 plants, water use efficiency, and heat tolerance in cereal crops. Grants & Funding: She has secured over $25M in research funding, leading projects on C4 photosynthesis, automated crop monitoring, and protected cropping systems. Notable collaborations include the ARC Centre of Excellence for Translational Photosynthesis and Future Food Systems CRC. Awards: 2024 Vice-Chancellor’s Excellence in Research Award 2023 Education and Outreach Award (Australian Society of Plant Scientists) 2001 ARC Postdoctoral Fellowship Labs & Teams: Her team develops innovative frameworks for sustainable horticulture, combining biology with AI and smart technologies. Ongoing work includes imaging-based crop monitoring and phenotyping for climate-resilient crops.
Dist. Professor Leslie Yeo is a distinguished faculty member at RMIT University's School of Engineering, where he leads the Micro/Nanophysics Research Laboratory (MNRL). With a PhD from Imperial College London (2002), he has held positions at Monash University and the University of Notre Dame before joining RMIT. His research focuses on the interactions between high-frequency sound waves and matter at micro and nanoscales. Leslie Yeo's educational background includes a PhD from Imperial College London (2002), where he received the Dudley Newitt prize for outstanding computational/theoretical work. Prior to his academic career, he worked as a Mathematical Modeller at Det Norske Veritas UK. He held prestigious Australian Research Fellowships (2009-2017) that supported his groundbreaking work in micro and nanophysics. Professor Yeo's research interests center around high-frequency (MHz order) sound waves interacting with various materials including fluids, two-dimensional and bulk crystals, biomolecules, cells and microorganisms. His work explores both fundamental physicochemical phenomena and practical applications in microfluidics, drug delivery, diagnostics, tissue engineering, and materials synthesis. His research has significant implications for health technologies, environmental applications, and sustainable energy solutions, aligning with UN Sustainable Development Goals 3 (Good Health and Well-Being) and 7 (Affordable and Clean Energy). Analysis of Professor Yeo's recent publications reveals a strong focus on acoustofluidics and its diverse applications. His work demonstrates expertise in using surface acoustic waves for bacterial inactivation, synthesis of metal-organic frameworks, cell membrane manipulation, and energy conversion technologies. The research spans multiple disciplines including biomedical engineering, materials science, and environmental technology, with particular emphasis on practical applications that address real-world challenges. 2023: Fellowship of the Institution of Engineering & Technology (FIET) 2021: RMIT University Science, Technology, Engineering & Medicine College Research Impact Award 2019: RMIT University Distinguished Professorship 2018: RMIT University Vice-Chancellor's Award for Research Excellence 2016: Johnson & Johnson World Without Disease Quickfire Challenge Award 2007: Young Tall Poppy Science Award Professor Yeo has supervised numerous research students across engineering and science disciplines, with current projects focusing on acoustomicrofluidic synthesis of nanomaterials, high-frequency mechanobiology applications, and diagnostic technologies. His editorial roles include Editor-in-Chief of the American Institute of Physics journal Biomicrofluidics and Associate Editor of Frontiers in Bioengineering & Biotechnology. His work has been widely featured in media outlets including ABC's Catalyst, The Economist, and Nature. The Micro/Nanophysics Research Laboratory under Professor Yeo's leadership is at the forefront of fundamental and applied research on nonlinear high-frequency electroacoustic interactions. The laboratory has discovered novel physicochemical phenomena and actively develops theories to explain the fundamental mechanisms behind these discoveries, with applications ranging from medical diagnostics to sustainable energy solutions.
Associate Professor Arnold Lining Ju is a biomedical engineer at the University of Sydney's School of Biomedical Engineering, affiliated with multiple institutes including the Heart Research Institute and Sydney Nano Institute. He holds academic positions in both the Faculty of Engineering and Faculty of Medicine & Health. Education: BSc from Peking University, PhD from Georgia Tech and Emory University (USA). Honors include Snow Fellowship, Heart Foundation Future Leader Fellowship, and multiple awards for cardiovascular research innovation. Research focuses on mechanobiology and biomechanics of thrombosis, developing microfluidic devices and organ-on-chip systems. Key projects include AI-driven single-cell nanotools, 3D biofabrication, and anti-thrombotic peptide design. Leads interdisciplinary teams and collaborates internationally with institutions like Harvard and University of Texas. Teaching roles include coordinating advanced cellular biomechanics courses and supervising PhD/Masters students in biomedical engineering and physiology. Over 50 peer-reviewed publications, with contributions to Nature Materials, Nature Communications, and other top journals.
Professor Gerard Sutton is an Honorary Professor in the Faculty of Medicine and Health at the University of Sydney, affiliated with the Save Sight Institute and Vision Eye Institute. He specializes in corneal and refractive surgery, combining clinical practice with research in keratoconus, corneal bioengineering, and global eye care. His work includes developing the Australian Corneal Bioengineering Centre and pioneering innovations like the Corneal Biopen for treating corneal defects. Research interests span clinical and laboratory-based studies, focusing on corneal transplantation, bioengineered treatments, and refractive surgery outcomes. Current projects include corneal bioengineering, keratoconus pathogenesis, and SMILE surgery clinical outcomes. He holds memberships in prominent ophthalmology societies like RANZCO and APPO. Awards: 2019 RANZCO John C. Parr Medal Lecture Award 2017 Sydney Research Centre ‘Big Idea’ Innovation Award 2015 XOVA Excellence in International Ophthalmology 2014 Asia Pacific Academy of Ophthalmology Achievement Award Grants & Funding: AU$35M BIENCO consortium (2023) for corneal blindness therapies AU$1.1M Corneal Biopen commercialization (2018) NHMRC Ideas Grant for bioengineered corneal layers (2019) His research group collaborates internationally, with projects addressing corneal transplantation equity, bioink development, and regenerative solutions for ocular surface diseases. Clinical affiliations include Sydney Eye Hospital and the Lions NSW Eye Bank.
Distinguished Professor Dayong Jin is a leading academic in nanotechnology and biomedical engineering at the University of Technology Sydney (UTS). He holds roles including Director of the Institute for Biomedical Materials and Devices (IBMD), ARC Laureate Fellow, and Chair Professor at Southern University of Science and Technology (China). His research focuses on photonics, luminescent materials, and their applications in healthcare, including cancer detection, rapid diagnostics, and super-resolution microscopy. Key innovations include 'Nano Torch' technology for disease detection and 'Super Dots' nanocrystals for imaging and anti-counterfeiting. Education: PhD from Macquarie University (2007). Leadership: Established UTS's IBMD and multiple research hubs, including the ARC IDEAL Research Hub and Australia-China Joint Research Centre. Research Interests: Transforming nanophotonics into diagnostic tools, rapid antigen tests (e.g., for COVID-19), and biomedical devices. His work bridges physics, engineering, and biology to address global health challenges. Awards: Australian Museum Eureka Prize (2015), Prime Minister's Prize for Science (2017), ARC Laureate Fellowship (2021), and Fellow of the Australian Academy of Technology and Engineering. Grants: Overseeing funded projects on quantum biotechnology, deep-tissue imaging, and nanoscale thermometry. Active in interdisciplinary collaborations, including with Chinese institutions. Labs/Teams: Leads IBMD, the ARC IDEAL Hub, and the UTS-SUSTech Joint Research Centre, fostering innovation in wearable biomaterials and point-of-care technologies.
Dr. Rebecca San Gil is a Lecturer at the School of Medical Sciences , University of Sydney, Australia. She leads the NeuroMolecular Discovery Group within the Neuroscience theme and is a member of the Charles Perkins Centre . Her research focuses on the molecular mechanisms underlying neurodegenerative diseases such as motor neuron disease (MND) and frontotemporal dementia (FTD) , with an emphasis on protein aggregation, stress responses, and therapeutic discovery. PhD, University of Wollongong (2018) Postdoctoral Research, Queensland Brain Institute (2018–2025) Endeavour Research Fellow (University College London) Her research spans molecular biology , neurosciences , and biochemistry , integrating techniques like genome-wide CRISPR screening , multi-omics analysis , and translational research . Key themes include the role of molecular chaperones , heat shock response , and protein folding dynamics in mitigating neurodegeneration. Dr. San Gil’s recent publications (2016–2025) highlight her work on TDP-43 pathology , heat shock proteins , and therapeutic strategies across ALS/FTD models. She has received awards such as the FightMND Early Career Research Fellow and the Sydney Dementia Network Future Research Leader Award (Travel Support Scheme) in 2025. Scientific Awards : FightMND Early Career Research Fellow, Sydney Dementia Network Future Research Leader Award (2025) Dr. San Gil actively mentors researchers like Celine CHYE and collaborates with institutions globally. Her team welcomes new members to explore neurodegenerative disease biology and therapeutic discovery .
Professor Trevor Lithgow is a Research Professor in Microbiology at Monash University, affiliated with the Monash Biomedicine Discovery Institute. He holds a PhD from La Trobe University (1992) and has held fellowships including the ARC Federation Fellowship (2008) and ARC Laureate Fellowship (2014). His research focuses on bacterial cell biology, antimicrobial resistance (AMR), and phage therapies, leveraging nanoscale imaging techniques like cryo-EM and super-resolution microscopy. He leads the Monash Centre to Impact AMR, an interdisciplinary initiative addressing global AMR challenges through collaborations across engineering, social sciences, and clinical medicine. Key achievements include the HFSP Tenth Anniversary Award (1999), Lemberg Medal (2020), and Royal Society of Victoria Medal (2017). His work on bacterial outer membrane assembly, phage-bacteria interactions, and structural analysis of the mitochondrial TOM complex has advanced understanding of pathogen resilience and novel antimicrobial strategies. Current projects include developing phage therapies and cross-sectoral AMR surveillance frameworks. Education: PhD in Biochemistry (La Trobe University, 1992) Research Interests: Bacterial cell surface visualization, nanoscale imaging, phage biology, AMR mechanisms Leadership: Director of Monash Centre to Impact AMR since 2020 Awards: 10+ national/international honors, including ARC Fellowships Publications span over 250 articles on bacterial membrane biology, AMR dynamics, and phage applications, with recent focus on polymyxin dependence in Acinetobacter and phage-driven resistance resensitization.
